Fundraising Fox
/People
Sign in

Gaurav Aggarwal

Investor

Managing Partner at Vivo Capital · Board director at Bonum Therapeutics

Menlo Park, California

Writes $10M – $50M checks · typically $25M

Find your path to Gaurav

386 people in our graph can introduce you to Gaurav.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Patrick Chang to introduce you to Gaurav

You →Patrick · together at Investor Growth Capital (2013) →Gaurav

Ask Jamie Chen to introduce you to Gaurav

You →Jamie · together at Investor Growth Capital →Gaurav

Ask Sam Okafor to introduce you to Gaurav

You →Sam · 8 people · together at Vivo Capital →Gaurav

Sign up to find every way you can get introduced to Gaurav

  • Your email: the people you already email who know Gaurav
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Gaurav
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Life sciences investor for over twenty years who rejoined Vivo as Managing Partner in 2024, having previously been Managing Director and CIO of the US public fund. Earned his M.D. from Columbia and a B.S. from Cornell.

Board director at Bonum Therapeutics

Intro paths

→

In turn, Gaurav can intro founders to Bonum Therapeutics's investors below.

Bonum Therapeutics's investors · 6

3x5 PartnersPortlandCodon CapitalSan Francisco · since 2022Digitalis VenturesNew York · $100K – $10M checks · since 2022RiverVest Venture PartnersSt. Louis · $500K – $3M checks · since 2026Roche Venture FundBasel · $648K – $3.2M checks · since 2022Vivo CapitalPalo Alto · $10M – $50M checks

Co-founders at Bonum Therapeutics

JMJohn Mulligan
John MulliganExecutive Officer, Director, Promoter

Experience

  1. Vivo CapitalChief Investment Officer - Opportunity Fundcurrent2021 — presentPalo Alto, California, United States
  2. Vivo CapitalManaging Directorcurrent2016 — present
  3. Ocera Therapeutics, Inc.Chief Business Officer2014 — 2016
  4. Investor Growth CapitalManaging Director2013
  5. Panorama CapitalPartner2006 — 2012
  6. JP Morgan PartnersAssociate2004 — 2006
  7. KBL Healthcare VenturesVice President1999 — 2004New York City Metropolitan Area
  8. Wasserstein PerellaAnalyst1997 — 1999New York City Metropolitan Area

Skills & more

Venture Capital18Due Diligence12Strategic Partnerships7Mergers & Acquisitions10Biopharmaceuticals7

From Gaurav's professional profile.

Colleagues at Vivo Capital

Albert Cha
Managing Partner at Frazier Life Sciences
Albert Chang
Executive Director, Head Trader at Vivo Capital
Allison Yan
Investor at Vivo Capital
Andrew Huang
Principal at Vivo Capital
Brad
Associate, IR at Vivo Capital
Chen Bian
Associate at Vivo Capital
Chen Meng
Managing Director at Vivo Capital
Chen Yu
Director at Vivo Capital

Network5

Albert Cha
Managing Partner at Frazier Life Sciences
Chen Bian
Associate at Vivo Capital
Daisy Xu
Managing Director at Vivo Capital
Daniel Qin
Associate at Vivo Capital
David Liu
Managing Director at Vivo Capital

Investors connected to Gaurav in public investor directories — a warm-intro map.

Frequently asked questions

Who is Gaurav Aggarwal?
Life sciences investor for over twenty years who rejoined Vivo as Managing Partner in 2024, having previously been Managing Director and CIO of the US public fund. Earned his M.D. from Columbia and a B.S. from Cornell.
Where does Gaurav Aggarwal work?
Gaurav Aggarwal is Managing Partner at Vivo Capital and Board director at Bonum Therapeutics.
What check size does Gaurav Aggarwal write?
Gaurav Aggarwal typically writes checks of $10M – $50M.
Where did Gaurav Aggarwal go to school?
Gaurav Aggarwal studied at Columbia University Vagelos College of Physicians and Surgeons (Doctor of Medicine (MD)); Cornell University (Bachelor's degree, Applied Economics).

Same school

Shared employers